Sequencing Strategies: Metastatic Pancreatic Adenocarcinoma

February 27th 2018

Balancing Efficacy and Quality of Life in Refractory CRC

February 17th 2018

New Concepts: Multimodal Approaches to Advanced NSCLC

January 30th 2018

New Treatment Strategies for Follicular Lymphoma

January 23rd 2018

Treatment of Nonmetastatic Castration-Resistant Prostate Cancer

December 28th 2017

Checkpoint Inhibitors in Advanced Bladder Cancer

December 28th 2017

Managing Treatment Decisions for Ovarian Cancer

December 23rd 2017

Updates in Advanced Gastric/GEJ Cancer Treatment

December 22nd 2017

Case-Based Insights on Multiple Myeloma

December 8th 2017

The Evolving Role of PARP Inhibitors in Ovarian Cancer

November 20th 2017

Collaborative Care in Soft Tissue Sarcoma

November 14th 2017

CDK4/6 Inhibitors for Hormone-Driven Breast Cancer

October 2nd 2017

Addressing Unmet Needs in Liver Cancer

September 8th 2017

Liquid Biopsy Use in Metastatic Non-Small Cell Lung Cancer

August 29th 2017

Minimal Residual Disease Assessment in Lymphoid Malignancies

August 29th 2017

The Evolving Landscape of Therapy for Follicular Lymphoma

August 15th 2017

AR-V7 Testing in Prostate Cancer

July 31st 2017

Optimal Therapeutic Management of Mantle Cell Lymphoma

July 26th 2017

Future Strategies in Kidney Cancer Treatment

July 17th 2017

The Evolving Landscape of Immunotherapy for NSCLC

July 13th 2017